Has the Chinese Pharma Industry valuation changed over the past few years?
|Thu, 27 Jan 2022||CN¥2.8t||CN¥721.5b||CN¥73.6b||32.7x|
|Sat, 25 Dec 2021||CN¥3.1t||CN¥718.2b||CN¥73.2b||36.2x|
|Mon, 22 Nov 2021||CN¥3.0t||CN¥716.8b||CN¥73.0b||31x|
|Wed, 20 Oct 2021||CN¥2.9t||CN¥705.1b||CN¥73.5b||30.5x|
|Fri, 17 Sep 2021||CN¥2.8t||CN¥702.8b||CN¥71.2b||31.5x|
|Sun, 15 Aug 2021||CN¥3.0t||CN¥702.6b||CN¥71.1b||30.4x|
|Thu, 10 Jun 2021||CN¥3.2t||CN¥680.8b||CN¥69.7b||34x|
|Wed, 03 Mar 2021||CN¥3.0t||CN¥646.4b||CN¥64.7b||32.2x|
|Sat, 05 Dec 2020||CN¥2.9t||CN¥635.4b||CN¥47.7b||35.2x|
|Tue, 08 Sep 2020||CN¥3.3t||CN¥626.5b||CN¥45.7b||43.1x|
|Mon, 01 Jun 2020||CN¥2.5t||CN¥629.7b||CN¥43.4b||39.2x|
|Thu, 05 Mar 2020||CN¥2.3t||CN¥644.0b||CN¥46.9b||34.3x|
|Sun, 08 Dec 2019||CN¥2.1t||CN¥630.2b||CN¥57.4b||28x|
|Sat, 31 Aug 2019||CN¥2.1t||CN¥621.0b||CN¥56.5b||28.8x|
|Tue, 04 Jun 2019||CN¥1.9t||CN¥609.5b||CN¥58.0b||30.1x|
|Fri, 08 Mar 2019||CN¥1.9t||CN¥594.7b||CN¥55.7b||30.7x|
Current Industry PE: Investors are relatively neutral on the industry at the moment, considering it's trading close to its 3-year average PE ratio of 33.8x. It appears they believe that earnings will grow in-line with historical growth rates.
Past Earnings Growth: The earnings for companies in the Pharmaceuticals industry have grown 9.7% per year over the last three years, and revenues for these companies have grown 6.7% per year. This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Which industries have driven the changes within the Chinese Pharma industry?
Industry PE: Investors are most optimistic about the Pharma industry, which is trading close to its 3-year average PE ratio of 33.8x. This is likely because analysts are expecting annual earnings growth of 24%, which is higher than its past year's earnings growth of 15% per year.
Forecasted Growth: Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 24% over the next 5 years. This is better than it's past earnings growth rate of 15% per year.
Which companies have driven the market over the last 7 days?
|2001 Zhejiang NHU||CN¥31.78||3.2%|
|300039 Shanghai Kaibao PharmaceuticalLtd||CN¥6.71||14.7%|
|605507 Guobang Pharma||CN¥31.33||4.7%|
|688166 BrightGene Bio-Medical Technology||CN¥33.50||2.9%|
|300584 Nanjing Hicin Pharmaceutical||CN¥35.80||8.1%|
Changchun High & New Technology Industry (Group)
Shanghai Fosun Pharmaceutical (Group)
Shijiazhuang Yiling Pharmaceutical
Shanghai Kaibao PharmaceuticalLtd
Yunnan Baiyao GroupLtd
BrightGene Bio-Medical Technology
Nanjing Hicin Pharmaceutical
North China Pharmaceutical
Jiangsu Hengrui Medicine
Zhangzhou Pientzehuang Pharmaceutical